Aligos Therapeutics, Inc IPO Research Information

Aligos Therapeutics, Inc IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Aligos Therapeutics, Inc, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Aligos Therapeutics, Inc	ALGS - NASDAQ	$14.00-$16.00	$15.00	$17.40	10 million	10/16/2020
Underwriter(s): J.P. Morgan, Jefferies, Piper Sandler
Co-Manager(s): Cantor
Industry: Health Care
Filing(s): Filed 2020-09-25 Terms Added 2020-10-09

Aligos Therapeutics, Inc Quote & Chart - Click for current quote - ALGS

About Aligos Therapeutics, Inc (adapted from Aligos Therapeutics, Inc prospectus):
They are a clinical-stage biopharmaceutical company currently focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ALGS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.